C&R Research stock price
씨엔알리서치KRX:359090 · KOSDAQ · HealthcareToday's signals · No active technical signal.
Signal details →C&R Research last closed at ₩2,280 (-0.65%) on 2026-10-02. Listed on KOSDAQ. Trailing 12 months PER is 15.8×. Its overall grade ranks 221 of 306 stocks in Healthcare.
About this company
C&R Research last closed at ₩2,280 (-0.65%) on 2026-10-02. Listed on KOSDAQ.
Details →Reported results
Position in sector
Healthcare · Overall C · 221/306
Valuation grade B
Dividends
2025 dividend per share · ₩10 · Yield 2.11%
Details →Recent filings
DART · received recent list, not a complete filing history. Factual information, not investment advice.
Related stocks
- 삼성바이오로직스Customer
임상시험수탁(CRO)·임상개발 관련 협력 가능성이 큰 국내 대형 바이오 고객
- 셀트리온Customer
바이오의약품 임상·허가·개발 관련 CRO 수요가 큰 주요 바이오 고객
- 유한양행Customer
신약개발 임상시험과 허가 대응에서 CRO 활용이 중요한 제약사
About C&R Research
- What technical signals does C&R Research (359090) have?
- C&R Research current technical signals: no active technical signal.
- Is C&R Research a cup-and-handle pattern?
- No. C&R Research has no valid Cup signal right now.
- What published figures are available for C&R Research?
- Market cap: KRW 26.21B. Trailing 12 months PER: 15.8×. Latest quarter PBR: 0.53×. Dividend yield: 2.11%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about C&R Research, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).